Consolidation & Interference in Multiple Sclerosis
1 other identifier
interventional
39
1 country
1
Brief Summary
The purpose of this research study is to investigate whether minimizing interference improves memory in multiple sclerosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable multiple-sclerosis
Started Mar 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 5, 2014
CompletedFirst Posted
Study publicly available on registry
March 7, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedAugust 1, 2016
July 1, 2016
1.2 years
March 5, 2014
July 28, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recall Proportion
2 hours
Study Arms (4)
Unfilled interference
EXPERIMENTALInterference onset: delayed test at 540000 ms
Early interference
EXPERIMENTALInterference onset: delayed test at 0 ms
Mid interference
EXPERIMENTALInterference onset: delayed test at 360000 ms
Late interference
EXPERIMENTALInterference onset: delayed test at 180000 ms
Interventions
Temporal duration of interference onset.
Eligibility Criteria
You may qualify if:
- If you are between the ages of 18-65.
- If you have a diagnosis of Multiple Sclerosis (MS) or are medically healthy.
- If you have MS, you have not had a flare up of MS symptoms in the past month.
- You do not have other neurological issues such as, Epilepsy or Stroke.
- You do not have a significant history of psychiatric problems or a current diagnosis of Major Depressive Disorder, Schizophrenia, Bipolar Disorder .
- You do not have a significant history of drug or alcohol abuse.
- You can read and speak English fluently.
- You are not currently taking steroids.
You may not qualify if:
- You are younger than 18 years old.
- You are older than 65 years old.
- You have had a prior stroke or neurological disease other than MS.
- You have a history of significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis) or a current diagnosis of Major Depressive Disorder, Bipolar Disorder.
- You have a significant alcohol or drug abuse history.
- You are currently taking steroids.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kessler Foundation
West Orange, New Jersey, 07052, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Visiting Scientist Neuropsychology & Neuroscience Research
Study Record Dates
First Submitted
March 5, 2014
First Posted
March 7, 2014
Study Start
March 1, 2014
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
August 1, 2016
Record last verified: 2016-07